Chen, R., Guo, S., Yang, C., Sun, L., Zong, B., Li, K., . . . Liu, S. (2020). Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer. Int J Oncol.
Style de citation ChicagoChen, Rui, et al. "Although C-MYC Contributes to Tamoxifen Resistance, It Improves Cisplatin Sensitivity in ER-positive Breast Cancer." Int J Oncol 2020.
Style de citation MLAChen, Rui, et al. "Although C-MYC Contributes to Tamoxifen Resistance, It Improves Cisplatin Sensitivity in ER-positive Breast Cancer." Int J Oncol 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.